Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluations

Bioorganic Chemistry 2026

View at publisher
Authors: Zainab M. Elsayed, Marwa Balaha, Haytham O. Tawfik, Eman F. Khaleel, Moataz A. Shaldam, Ahmed T. Negmeldin, Ghada H. Al-Ansary, Diaaeldin M. Elimam, Yasser M. Omar, Viviana di Giacomo, Wagdy M. Eldehna
DOI: 10.1016/j.bioorg.2026.109790
Cited by: 4
References: 59

Fields of Study & Subjects

Cancer-related Molecular Pathways Advanced Breast Cancer Therapies Click Chemistry and Applications

Publication details

Journal / source
Bioorganic Chemistry
Publisher
Elsevier BV
Volume
175
Pages
109790–109790
Publication date
26 March 2026
Language
EN